Health-Adjusted Premium Subsidies In The Netherlands

Wynand P.M.M. van de Ven, René C.J.A. van Vliet, Leida M. Lamers

Health Affairs · 2004 · 74 citations · 16 references

Concepts

Abstract

The Dutch government has decided to proceed with managed competition in health care. In this paper we report on progress made with health-based risk adjustment, a key issue in managed competition. In 2004 both Diagnostic Cost Groups (DCGs) computed from hospital diagnoses only and Pharmacy-based Cost Groups (PCGs) computed from out-patient prescription drugs are used to set the premium subsidies for competing risk-bearing sickness funds. These health-based risk adjusters appear to be effective and complementary. Risk selection is not a major problem in the Netherlands. Despite the progress made, we are still faced with a full research agenda for risk adjustment in the coming years.

References

16